1.A clinical analysis and follow up study of stomach cancer.
Jong Ryul LEE ; Kyoung Ho SEO ; Il Dong JUNG ; Bong Kweon CHUN ; Doo Bok PARK
Journal of the Korean Surgical Society 1993;44(2):196-207
No abstract available.
Follow-Up Studies*
;
Stomach Neoplasms*
;
Stomach*
2.Pulmonary lymphangiomyomatosis.
Soo Sang JUNG ; Byeng Ryul PARK ; Jong Su LEE ; Seok Sung YANG
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(2):160-163
No abstract available.
Lymphangioleiomyomatosis*
3.Mediastinal glomus tumor.
Soo Sang JUNG ; Byeng Ryul PARK ; Jong Su LEE ; Seok Sung YANG ; Tae Won LEE
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(3):241-244
No abstract available.
Glomus Tumor*
4.Hyperbilirubinemia after heart surgery.
Jong Ho PARK ; Jeong Ryul LEE ; Hyuk ANH ; Hurn Chae CHAE ; Kyung Phill SUH
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(3):170-179
No abstract available.
Heart*
;
Hyperbilirubinemia*
;
Thoracic Surgery*
5.A study on the relationship between HBeAg and hepatitis B virus DNAamong healthy HBsAg carries.
Yoo Sik HAHM ; Hai Rim SHIN ; Hyung Jong PARK ; Sung Ryul KIM
Korean Journal of Epidemiology 1992;14(1):48-58
No abstract available.
Hepatitis B e Antigens*
;
Hepatitis B Surface Antigens*
;
Hepatitis B virus*
;
Hepatitis B*
;
Hepatitis*
6.Surgical Management of Chronic Lymphedema of Penis and Scrotum.
Woong NA ; Chong Won PARK ; Jong Ryul IM ; Jong Bouk LEE ; Han CHUNG
Korean Journal of Urology 2005;46(3):306-309
Chronic lymphedema of the penis and scrotum is a rare disease in Korea. Lymphedema can be defined as an accumulation of excessive lymph, proteins, chronic inflammation, edema and fibrosis, secondary to the impairment of the lymph vessels, which can be classified into primary, which is the result of inadequate drainage of lymph caused by agenesis and hypogenesis of lymph vessels, and secondary, which could be due to an obstruction or interruption of the lymphatic system, caused by malignancies, post-operative, post-radiation fibrosis, infection, trauma or excision. The treatment method for a lymphedema of the genitalia is determined by cause, which is crucial to the natural course of the disease. In contrast to a primary lymphedema without soft tissue changes and injury, which could be treated conservatively, surgical excision is the best method to treat a chronic lymphedema with soft tissue changes. In this article, a case of penile and scrotal chronic lymphedema of unknown cause, treated with surgical methods, is reported.
Drainage
;
Edema
;
Fibrosis
;
Genitalia
;
Inflammation
;
Korea
;
Lymphatic System
;
Lymphedema*
;
Male
;
Penis*
;
Rare Diseases
;
Scrotum*
;
Surgical Procedures, Operative
7.The Short Term Efficacy of Entecavir Therapy in Chronic Hepatitis B.
Hyun KIM ; Hee Bok CHAE ; Won Joong JEON ; Seon Mee PARK ; Sei Jin YOUN ; Jong Ryul EUN ; Heon Ju LEE
Yeungnam University Journal of Medicine 2008;25(1):31-40
BACKGROUND/AIMS: Entecavir is a synthetic nucleoside analogue, cyclopentyl guanine nucleoside, which has a potent antiviral effect and the least viral breakthrough in hepatitis B virus (HBV) replication. Entecavir has been available in Korea since 2007 but there are few reports on its effects. The aim of this study was to evaluate the virological response (VR) and biochemical response (BR) to entecavir in HBV patients at 3, 6 and 9 months after treatment with entecavir. MATERIALS AND METHODS: Thirty-three chronic hepatitis B patients who took entecavir for at least 9 months were enrolled. We investigated VR and BR by retrospectively reviewing medical records. Patients who satisfied the following criteria were chosen: 1) initial alanine aminotransferase (ALT) levels = 1.5upper limit of normal (ULN) and 2) initial HBV DNA levels = 5 log10 copies/ml. We measured ALT levels every 3 months until month 9. HBV DNA was measured every 2 or 3 months by polymerase chain reaction (PCR) method. RESULTS: Most patients taking entecavir showed good BR (ALT < 40 IU/L). The BR rates were 61%, 73% and 67% at months 3, 6 and 9, respectively. VR (HBV DNA < 5 log(10) copies/ml or 2 log lower than initial HBV DNA) rates were 82%, 91% and 91% at months 3, 6 and 9, respectively. Undetectable HBV DNA (HBV DNA < 4 log(10) copies/ml) rates were 49%, 73% and 85% at months 3, 6 and 9, respectively. Two patients presented with virological breakthrough without adverse effects until month 9. CONCLUSIONS: Entecavir showed good BR and VR from month 3 and these effects continued through the 9-month observation period. This suggests that entecavir is also a good choice for the first line treatment of chronic hepatitis B (CHB). Further studies are needed to determine the long-term efficacy and drug resistance of entecavir in Korean CHB patients.
Alanine Transaminase
;
DNA
;
Drug Resistance
;
Guanine
;
Hepatitis B virus
;
Hepatitis B, Chronic
;
Hepatitis, Chronic
;
Humans
;
Korea
;
Medical Records
;
Polymerase Chain Reaction
;
Retrospective Studies
8.A Case Report of Disseminated Extranodal Marginal Zone B-Cell Lymphoma of MALT Manifested by Solitary Pulmonary Nodule.
Joon Hyun CHO ; Jong Pil JUNG ; Hee Jeong CHA ; Chang Ryul PARK ; Sung Ryul KIM ; Hawk KIM ; Jin Woo PARK ; Soon Joo WOO ; Eun A EUM ; Ki Young LEE ; Yang Jin JEGAL
Tuberculosis and Respiratory Diseases 2006;61(2):171-177
Extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma) is usually indolent. Although it was reported recently that about 20-30% cases of MALT lymphoma presented with a disseminated disease at diagnosis, it was described as a disease localized at diagnosis and remaining stable for a prolonged period. However, only a few cases of MALT lymphoma involved the lung and gastrointestinal tract all at once. We report a case of a 73-year-old man with disseminated MALT lymphoma. He presented with non-productive cough, initial chest radiograph showed a nodule in the right lower lobe. The diagnosis of stage IV MALT lymphoma was made by CT scan, video-assisted thoracoscopic excisional biopy, gastrofiberscopic biopsy and bone marrow biopsy. The lymphoma involved the lung, stomach and bone marrow at the time of diagnosis. Because he refused chemotherapy, he discharged after Helicobacter pylori eradication without chemotherapy. Regular follow-up examination did not show any evidence of disease progression over 22 months.
Aged
;
Biopsy
;
Bone Marrow
;
Cough
;
Diagnosis
;
Disease Progression
;
Drug Therapy
;
Follow-Up Studies
;
Gastrointestinal Tract
;
Helicobacter pylori
;
Humans
;
Lung
;
Lymphoid Tissue
;
Lymphoma
;
Lymphoma, B-Cell, Marginal Zone*
;
Radiography, Thoracic
;
Solitary Pulmonary Nodule*
;
Stomach
;
Tomography, X-Ray Computed
9.A Study on Iron Status and Anemia of Rural and Urban Middle School Students in Ulsan.
Sang Kyu PARK ; Hyun Mi KIM ; Jin Yeong JEONG ; Sung Jong PARK ; Jae Hoo PARK ; Sung Ryul KIM ; Soon Myung HONG
Korean Journal of Pediatric Hematology-Oncology 1999;6(2):235-249
PURPOSE: This study was aimed at assessing the difference of the prevalence of iron deficiency and iron deficiency anemia among rural and urban middle school students in relation to dietary habit. METHODS: With a questionnaire, blood samples were obtained from 439 apparently healthy rural and urban middle school students residing in Ulsan. Anemia was defined as hemoglobin level of 12.6 g/dL or less for boys and 11.9 g/dL or less for girls. Iron deficiency was defined as serun ferritin level less than 12 micrograms/L or/and transferrin saturation less than 14%. Iron deficiency anemia was defined as iron deficiency plus low hemoglobin. RESULTS: 1) In boys, the prevalence rate of anemia was 17.2%. Among these anemias, 5.4% were found to be iron deficiency anemia. In girls, the prevalence of anemia increased with age. The prevalence of iron deficiency anemia was 6.9%. 2) In girls, the prevalence rate of anemia in rural area was higher than that of anemia in urban area (12.6% in rural, 6.1% in urban, P<0.01). 3) The prevalence of anemia and iron deficiency in the students with menstruation was 10.6% and 33.1%, which was higher than the prevalence of 2.5% and 7.5% in those who did not have the menarche (P<0.001 and P<0.001, respectively). 4) Dietary intake of rural and urban middle school students was estimated lower in energy, iron than the recommeded dietary allowance (RDA). In girls, dietary intake of rural middle school students was estimated lower in iron, niacin, and vitamin C than that of urban middle school students. 5) Nutritional factors such as energy, carbohydrate, protein, and phosphorus showed positive correlation with RBC, hemoglobin (P<0.05). CONCLUSION: It is recommended to enforce the nutritional education to take enough iron in middle school students to reduce the high prevalence rate of anemia among pubertal students.
Anemia*
;
Anemia, Iron-Deficiency
;
Ascorbic Acid
;
Education
;
Female
;
Ferritins
;
Food Habits
;
Humans
;
Iron*
;
Menarche
;
Menstruation
;
Niacin
;
Phosphorus
;
Prevalence
;
Surveys and Questionnaires
;
Transferrin
;
Ulsan*
10.A case of acute profound thrombocytopenia following abciximab therapy.
Jin Woo KIM ; Seon Ho LEE ; Seung Ryul KIM ; Jong Ho PARK ; Yung Joo MIN ; Jae Hoo PARK
Korean Journal of Medicine 2002;62(4):475-481
Bleeding and thrombocytopenia are important adverse effects of abciximab. The incidence of abciximab-induced acute profound thrombocytopenia (APT) is low. APT is defined as an abrupt drop in platelet count to <20,000/microL that occurred within 24 hours of administration of an abciximab. This is distinct from all other types of drug-induced thrombocytopenia, which requires a period of drug administration to induce sensitization. If APT occurs and is left untreated, it can cause serious hemorrhage and ischemia that may be fatal. In this case, a 45-year-old man with acute myocardial infarction was administered a bolus intravenous injection of abciximab (0.25 mg/kg), followed by a 12-hour continuous infusion (10 microgram/min) during primary coronary angioplasty. We report a case of APT that was recognized at 2 hours after the initiation of abciximab infusion and was corrected without serious complications.
Angioplasty
;
Hemorrhage
;
Humans
;
Incidence
;
Injections, Intravenous
;
Ischemia
;
Middle Aged
;
Myocardial Infarction
;
Platelet Count
;
Thrombocytopenia*